|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection显示文摘It has been known that,the novel coronavirus,2019-nCoV,which is considered similar to SARS-CoV,invades human cells via the receptor angiotensin converting enzyme II(ACE2).Moreover,lung cells that have ACE2 expression may be the main target cells during 2019-nCoV infection.However,some patients also exhibit non-respiratory symptoms,such as kidney failure,implying that 2019-nCoV could also invade other organs.To construct a risk map of different human organs,we analyzed the single-cell RNA sequencing(scRNA-seq)datasets derived from major human physiological systems,including the respiratory,cardiovascular,digestive,and urinary systems.Through scRNA-seq data analyses,we identified the organs at risk,such as lung,heart,esophagus,kidney,bladder,and ileum,and located specific cell types(i.e.,type II alveolar cells(AT2),myocardial cells,proximal tubule cells of the kidney,ileum and esophagus epithelial cells,and bladder urothelial cells),which are vulnerable to 2019-nCoV infection.Based on the findings,we constructed a risk map indicating the vulnerability of different organs to 2019-nCoV infection.This study may provide potential clues for further investigation of the pathogenesis and route of 2019-nCoV infection. | Xin Zou Ke Chen Jiawei Zou Peiyi Han Jie Hao Zeguang Han | 2020 | Frontiers of Medicine2020，14，2： | 193 |
| 2 | High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa显示文摘It has been reported that ACE2 is the main host cell receptor of 2019-nCoV and plays a crucial role in the entry of virus into the cell to cause the final infection. To investigate the potential route of 2019-n Cov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including The Cancer Genome Atlas(TCGA) and Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression(FANTOM5 CAGE) dataset were collected. RNA-seq profiling data of 13 organ types with para-carcinoma normal tissues from TCGA and 14 organ types with normal tissues from FANTOM5 CAGE were analyzed in order to explore and validate the expression of ACE2 on the mucosa of oral cavity. Further, single-cell transcriptomes from an independent data generated in-house were used to identify and confirm the ACE2-expressing cell composition and proportion in oral cavity. The results demonstrated that the ACE2 expressed on the mucosa of oral cavity. Interestingly, this receptor was highly enriched in epithelial cells of tongue. Preliminarily, those findings have explained the basic mechanism that the oral cavity is a potentially high risk for 2019-nCoV infectious susceptibility and provided a piece of evidence for the future prevention strategy in dental clinical practice as well as daily life. | Hao Xu Liang Zhong Jiaxin Deng Jiakuan Peng Hongxia Dan Xin Zeng Taiwen Li Qianming Chen | 2020 | International Journal of Oral Science2020，12，1： | 69 |
| 3 | RAS抑制剂是治疗新型冠状病毒肺炎的可能选择之一显示文摘新型冠状病毒通过与人体血管紧张素转化酶2(ACE2)结合感染产生重症肺炎,传染性强,病死率高,目前无确切有效的治疗方式。ACE2是肾素-血管紧张素系统(RAS)的重要组成部分,RAS系统中ACE/Ang II/AT1R通路与ACE2/Ang(1-7)/Mas受体通路失衡将导致多系统炎症。ACE和Ang II升高是重症肺炎的不良预后因素。动物实验结果显示,应用RAS抑制剂可以有效缓解急性重症肺炎症状,缓解呼吸衰竭。新型冠状病毒与ACE2的结合导致ACE2耗竭,ACE2/Ang (1-7)/Mas受体通路受到抑制,RAS系统失衡,使新型冠状病毒肺炎患者病死率升高。因此,在控制血压的情况下,对新型冠状病毒肺炎患者应用ACEI及AT1R抑制剂,有可能减轻患者肺部炎症反应,降低患者病死率。 | 孙美丽 杨建民 孙玉萍 苏国海 | 2020 | 中华结核和呼吸杂志2020，43，3： | 44 |
| 4 | 新型冠状病毒(2019-nCoV)相关研究进展显示文摘自2019年12月底,湖北武汉暴发新型冠状病毒(2019-nCoV)感染疫情,截至2020年2月20日全国发现感染病例累计7万余例,2019-nCoV传播速度快,影响大。为尽快了解2019-nCoV感染的发生、发展进程,本文对2019-nCoV相关研究进行综述,以进一步了解其致病机制,科学、合理的采取诊疗措施,积极预防和控制疫情。 | 周娟 李丹 龙云铸 | 2020 | 中国感染控制杂志2020，19，3： | 38 |
| 5 | AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells显示文摘The current coronavirus disease 2019(COVID-19)pandemic presents a global public health challenge.The viral pathogen responsible,severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),binds to the host receptor ACE2 through its spike(S)glycoprotein,which mediates membrane fusion and viral entry.Although the role of ACE2 as a receptor for SARS-CoV-2 is clear,studies have shown that ACE2 expression is extremely low in various human tissues,especially in the respiratory tract.Thus,other host receptors and/or co-receptors that promote the entry of SARS-CoV-2 into cells of the respiratory system may exist.In this study,we found that the tyrosine-protein kinase receptor UFO(AXL)specifically interacts with the N-terminal domain of SARS-CoV-2 S.Using both a SARS-CoV-2 virus pseudotype and authentic SARS-CoV-2,we found that overexpression of AXL in HEK293T cells promotes SARS-CoV-2 entry as efficiently as overexpression of ACE2,while knocking out AXL significantly reduces SARS-CoV-2 infection in HI 299 pulmonary cells and in human primary lung epithelial cells.Soluble human recombinant AXL blocks SARS-CoV-2 infection in cells expressing high levels of AXL.The AXL expression level is well correlated with SARS-CoV-2 S level in bronchoalveolar lavage fluid cells from COVID-19 patients.Taken together,our findings suggest that AXL is a novel candidate receptor for SARS-CoV-2 which may play an important role in promoting viral infection of the human respiratory system and indicate that it is a potential target for future clinical intervention strategies. | Shuai Wang Zongyang Qiu Yingnan Hou Xiya Deng Wei Xu Tingting Zheng Peihan Wu Shaofang Xie Weixiang Bian Chong Zhang Zewei Sun Kunpeng Liu Chao Shan Aifu Lin Shibo Jiang Youhua Xie Qiang Zhou Lu Lu Jing Huang Xu Li | 2021 | Cell Research2021，31，2： | 39 |
| 6 | 新型冠状病毒公认受体血管紧张素转换酶2的单细胞RNA表达情况显示文摘研究发现,2019新型冠状病毒与严重急性呼吸综合征-冠状病毒(severe acute respiratory syndromecoronavirus,SARS-CoV)存在相同的受体———血管紧张素转换酶2(angiotensin converting enzyme 2,ACE2)。在此,研究者基于公共数据库和最新的单细胞转录组测序技术,分析了ACE2RNA在正常人肺中的表达谱。结果表明,ACE2的表达集中在一小部分Ⅱ型肺泡上皮细胞中。 | 刘青(译) 叶鹏(审校) Zhao Y Zhao Z Wang Y Zhou Y Ma Y Zuo W | 2020 | 中华高血压杂志2020，28，3： | 24 |
| 7 | 三七总皂苷对心梗后心室重构大鼠ACE2与TNF-α表达的影响显示文摘目的:研究三七总皂苷(PNS)对急性心肌梗塞后左室重构血管紧张素转换酶2(ACE2)与大鼠肿瘤坏死因子α(TNF-α)表达的影响。方法:采用结扎大鼠左冠状动脉前降支的方法建立AM I模型,术后24 h后随机分为对照组和实验组,连续4 w分别灌胃给予生理盐水、福辛普利及PNS低、中、高剂量,观察PNS对病鼠血清丙二醛(MDA)、一氧化氮(NO)、ACE2、TNF-α含量及谷胱甘肽过氧化物酶(GSH-Px)的影响。结果:PNS与福辛普利均能显著降低MDA含量,提高GSH-Px活性(P<0.05或P<0.01),高剂量PNS还能显著降低NO含量(P<0.05),PNS低、中、高剂量均能促进ACE2的释放,并减少TNF-α的表达(P<0.05)。结论:PNS可通过促进病鼠ACE2的释放,抑制脂质过氧化反应及TNF-α的释放,减轻心肌细胞损伤,保护心肌,改善心室重构。 | 郭洁文 李丽明 邱光清 邓志军 符永恒 杨敏 潘竞锵 刘若轩 | 2010 | 中药材2010，33，1： | 22 |
| 8 | 新型冠状病毒肺炎的消化系统特征与粪口传播问题显示文摘自2019年12月至2020年3月,全国累计超八万余人被确诊为新型冠状病毒肺炎(Novel Coronavirus Pneumonia,NCP),简称新冠肺炎;2020年2月WHO将其命名为2019冠状病毒病(Corona Virus Disease 2019,COVID-19)。COVID-19由感染新型冠状病毒(SARS-CoV-2)引起,SARS-CoV-2与此前流行的严重急性呼吸综合征冠状病毒(SARSCoV)、中东呼吸综合征冠状病毒(MERS-CoV)同为β属冠状病毒,其中SARS-CoV通过细胞受体血管紧张素转化酶Ⅱ(ACE2)进入宿主细胞,最近研究指出,ACE2也是SARS-CoV-2的受体。ACE2不仅在肺泡细胞高表达,在食管、回肠、结肠上皮细胞中也有较高表达,说明消化系统可能为SARS-CoV-2感染的潜在途径[1]。 | 周琬琰 陈烨 | 2020 | 现代消化及介入诊疗2020，25，2： | 23 |
| 9 | 血管紧张素转换酶2与高血压显示文摘肾素血管紧张素系统(renin-angiotensin system,RAS)和激肽释放酶-激肽系统是机体内调控血压稳定的两大体系,它们之间相互对抗,同时又形成多层次的相互作用的网络.在整个血压调控网络中,血管紧张素转换酶(angiotensin-converting enzyme,ACE)及其新近发现的同源酶ACE2是其中的关键作用子[1]. | 钟久昌 朱鼎良 | 2005 | 高血压杂志2005，13，11： | 20 |
| 10 | Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury显示文摘The 2019-nCoV viral infection causes clusters of severe respiratory illness such as an acute respiratory distress syndrome(ARDS)similar to that caused by SARS-CoV(severe acute respiratory syndrome coronavirus)(Huang et al.2020).Both 2019-nCoV and SARS-CoV use the same receptor,ACE2(angiotensin converting enzyme 2). | Yuntao Wu | 2020 | Virologica Sinica2020，35，3： | 19 |
| 11 | Single-cell transcriptome analysis of the novel coronavirus (SARS-CoV-2) associated gene ACE2 expression in normal and non-obstructive azoospermia (NOA) human male testes显示文摘Being infected by SARS-CoV-2 may cause damage to multiple organs in patients, such as the lung, liver and heart. Angiotensin-converting enzyme 2(ACE2), reported as a SARS-CoV-2 receptor, is also expressed in human male testes. This suggests a potential risk in human male reproductive system. However, the characteristics of ACE2-positive cells and the expression of other SARS-CoV-2 process-related genes are still worthy of further investigation. Here, we performed singlecell RNA seq(scRNA-seq) analysis on 853 male embryo primordial germ cells(PGCs) and 2,854 normal testis cells to assess the effects of the SARS-CoV-2 virus on the male reproductive system from embryonic stage to adulthood. We also collected and constructed the scRNA-seq library on 228 Sertoli cells from three non-obstructive azoospermia(NOA) patients to assess the effects at disease state. We found that ACE2 expressing cells existed in almost all testis cell types and Sertoli cells had highest expression level and positive cells ratio. Moreover, ACE2 was also expressed in human male PGCs. In adulthood, the level of ACE2 expression decreased with the increase of age. We also found that ACE2 positive cells had high expressions of stress response and immune activation-related genes. Interestingly, some potential SARS-CoV-2 process-related genes such as TMPRSS2, BSG, CTSL and CTSB had different expression patterns in the same cell type. Furthermore, ACE2 expression level in NOA donors’ Sertoli cells was significantly decreased. Our work would help to assess the risk of SARS-CoV-2 infection in the male reproductive system. | Xixi Liu Yidong Chen Wenhao Tang Li Zhang Wei Chen Zhiqiang Yan Peng Yuan Ming Yang Siming Kong Liying Yan Jie Qiao | 2020 | Science China(Life Sciences)2020，63，7： | 14 |
| 12 | 苯那普利与厄贝沙坦对心衰大鼠心室重构过程中AngⅡ受体及ACE2的影响显示文摘目的探讨苯那普利、厄贝沙坦及两者联合用药对心衰大鼠心室重构过程中心肌血管紧张素Ⅱ1型受体(AT1R)、2型受体(AT2R)及ACE2蛋白表达的影响。方法采用大鼠腹主动脉缩窄法造成压力负荷性心肌肥厚致心力衰竭模型。苯那普利或(和)厄贝沙坦连续给药8wk,检测血流动力学参数、心脏指数、心肌和血浆AngⅡ含量、心肌中AT1R、AT2R和ACE2蛋白的表达情况。结果模型组心脏指数、LVEDP、血浆和心肌AngⅡ的含量及心肌AT1R、AT2R和ACE2蛋白的表达明显升高;各治疗组心脏指数、LVEDP明显下降;苯那普利组血浆和心肌AngⅡ的含量降低,厄贝沙坦组心肌AT1R蛋白的表达明显下降而AT2R和ACE2蛋白的表达明显升高,联合应用具有协同作用。结论联合应用苯那普利和厄贝沙坦对改善心衰大鼠心室重构具有协同作用,可能与AngⅡ和AT1R的下调而AT2R和ACE2的上调有关。 | 任亚丽 徐济良 虞珏 孟国梁 赵喜 吴锋 | 2008 | 中国药理学通报2008，24，12： | 13 |
| 13 | 鱼腥草提取物对慢阻肺大鼠肺组织ACE2及p38MAPK通路的影响显示文摘目的:探究鱼腥草提取物对慢阻肺大鼠肺组织血管紧张素转换酶2(ACE2)及p38丝裂原活化蛋白激酶(p38MAPK)通路的影响。方法:清洁级SD大鼠60只,随机分为空白组、模型组、富露施组及鱼腥草水提物低、中、高剂量组,各10只。除空白组外大鼠通过烟熏和脂多糖(LPS)气道滴入方法建立慢阻肺模型,空白组大鼠不做任何处理。第2次注射LPS后起,鱼腥草水提物低、中、高剂量组每天给药量分别为0.27g/200g、0.54g/200g、1.08g/200g,富露施组为10.8g/200g,其余两组给予等量蒸馏水。给药4周后,测定大鼠用力肺活量(FVC)、第0.1秒用力呼气容积(FEV0.1)和呼气峰流速(PEF);统计肺泡灌洗液白细胞数目及各分类比;苏木精-伊红(HE)染色观察肺组织病理变化;蛋白质印迹(Western blot)检测肺组织ACE2、p38MAPK、p-p38MAPK水平。结果:造模后大鼠FVC、FEV0.1、PEF水平较空白组均显著降低(P<0.05),富露施、鱼腥草水提物干预后FVC、FEV0.1、PEF水平较模型组均显著升高(P<0.05),且有剂量依赖关系。模型组肺泡灌洗液白细胞数较空白组显著升高(P<0.05),经富露施、中及高剂量鱼腥草水提物干预后白细胞数较模型组显著下降(P<0.05),但仍高于空白组(P<0.05);各组间巨噬细胞比率差异无统计学意义(P>0.05);模型组、富露施组和鱼腥草水提物低剂量组淋巴细胞比率较空白组显著下降(P<0.05);造模后中性粒细胞比率较空白组均显著升高(P<0.05),各治疗组中性粒细胞比率较模型组均显著降低(P<0.05)。HE染色发现,模型组支气管壁有大量炎性细胞附着,气管黏膜上皮坏死、脱落、杂乱,杯状细胞及腺体显著增生;富露施、鱼腥草水提物干预后支气管炎症及破坏程度明显较轻。Western blot结果显示,模型组肺组织ACE2水平较空白组显著升高(P<0.05),富露施、鱼腥草水提物干预后ACE2水平较模型组显著升高(P<0.05);各组大鼠肺组织p38MAPK水平无显著差异(P>0.05);模型组肺组织p-p38MAPK水平较空白组显著升高(P<0.05),富露施、鱼腥草水提物干预后p-p38MAPK水平较模型组显著降低(P<0.05)。结论:鱼腥草水提物能明显减轻慢阻肺大鼠的肺脏损伤程度,其机制可能与ACE2活化及p38MAPK通路受到抑制有关。 | 余欢 李良春 谈明欣 | 2018 | 四川中医2018，36，8： | 12 |
| 14 | 参元益气活血胶囊对不稳定型心绞痛气虚血瘀证患者择期PCI围术期ACE2的影响显示文摘目的:观察参元益气活血胶囊对择期经皮冠状动脉介入(PCI)气虚血瘀者患者围术期ACE2的影响,探讨该药的临床新用途。方法:采用前瞻性、随机、双盲、安慰剂、对照的临床试验方案观察对照组及观察组对择期PCI的不稳定型心绞痛(UA)患者血清中ACE2、ERK、PKC水平的影响,同时观察参元益气活血胶囊对择期PCI围术期心绞痛的临床疗效。结果:2组PCI术前ACE2、ERK、PKC差异无统计学意义(P>0.05);对照组术后血清中ACE2、ERK、PKC水平有所升高,提示存在一定的围术期心肌损伤;观察组术后血清中ACE2、ERK、PKC水平较术前水平升高,与对照组比较差异有统计学意义(P<0.05)。2组患者PCI术后心绞痛发作均明显减少,显效率相当,总有效率观察组略高,但差异无统计学意义(P>0.05)。结论:参元益气活血胶囊对择期PCI围术期心肌损伤具有一定的保护作用。 | 李爱勇 张玉灵 邢文龙 尚菊菊 刘红旭 | 2017 | 世界中医药2017，12，2： | 11 |
| 15 | 肾素—血管紧张素系统的重大发现—ACE2与Ang(1~7)显示文摘肾素—血管紧张素系统 (renin angiotensinsystem ,RAS)是最重要的心血管系统体液调节机制之一 ,最近发现了这一系统的许多新成员 ,包括ACE2、Ang -( 1~ 7)、Ang -( 1~ 9)等 。 | 翁智远 晋学庆 吴可贵 | 2004 | 高血压杂志2004，12，3： | 11 |
| 16 | 高血压大鼠ACE2的表达及其与一氧化氮相关性分析显示文摘目的探讨血管紧张素转换酶2(ACE2)在自发性高血压大鼠(SHR)中的表达情况并对其与血清一氧化氮(NO)水平作相关性分析。方法分别采用实时荧光定量PCR,Northern印迹以及免疫印迹技术测定心、肾组织中ACE2的mRNA与蛋白表达情况,同时用硝酸还原酶法检测血清NO含量。结果与WKY对照组相比,SHR大鼠心、肾组织中ACE2的mRNA和蛋白表达均明显下降(ACE2/GAPDH mRNA拷贝数比值为:心脏0·043±0·012vs1.291±0·619;肾脏0·051±0·016vs0·914±0·433,P均<0·01;蛋白相对OD值为:心脏0·729±0·046vs1±0·053;肾脏0·734±0·063vs1.005±0·05,P均<0·01),同时出现血清NO浓度下降[(24.3±8.0vs78.4±27.9)μmol/L,P<0·01)。相关分析发现,大鼠血清NO水平与心、肾组织中ACE2/GAPDH的mRNA拷贝数比值呈正相关(r=0·610,0·521,P均<0·05),而与血压水平则呈负相关(r=-0·656,P<0·05)。结论SHR大鼠心、肾组织中ACE2的mRNA和蛋白表达均明显下降,很可能与体内NO水平降低及血压上升有关。特异性影响ACE2转录和表达的药物将对高血压病的防治有重要的临床应用价值。 | 钟久昌 黄东阳 余细勇 | 2005 | 高血压杂志2005，13，9： | 10 |
| 17 | 流感病毒H1N1、高致病性禽流感病毒H5N1和SARS-CoV、MERS-CoV及2019-nCoV所致病理改变及其致病机制的比较显示文摘我国武汉出现的新型冠状病毒肺炎疫情经过迅速发展已对全国造成严重影响,但到目前为止对新型冠状病毒肺炎病理变化和发病机制却知之甚少。该文总结重症流感病毒H1N1、高致病性禽流感病毒H5N1、SARS-CoV、MERS-CoV及2019-nCoV几种引起重大疫情病毒感染性疾病的病理改变,尸检肺组织均表现为弥漫性肺泡损伤(diffuse alveolar damage,DAD),但不同病毒引起的病理表现存在差异,重症流感病毒2009 H1N1病毒与受体α-2,6-SA及α-2,3-SA结合,除DAD病变外,常伴有上呼吸道、气管、支气管和细支气管的炎性病变,且较易合并细菌感染。高致病性禽流感病毒H5N1主要结合α-2,3-SA受体,主要累及肺泡上皮及细支气管,少见上呼吸道及气管、支气管病变,常伴局灶肺出血及肺组织坏死,机化及纤维化较少见。SARS-CoV通过结合血管紧张素转换酶2(ACE2)进入细胞,病变与病程相关,DAD渗出期一般见于病程10~14 d死亡患者。病程大于10 d患者表现为DAD机化期,并常伴有闭塞性细支气管炎伴机化性肺炎样改变及肺泡腔内显著多核巨细胞。SARS-CoV及H5N1感染患者肺外器官均可见脾和淋巴结内淋巴细胞耗竭、急性肾小管坏死、骨髓内噬血细胞现象。 | 刘敏 冯瑞娥 李倩 张红凯 王玉光 | 2020 | 中华病理学杂志2020，49，5： | 10 |
| 18 | 血管紧张素转换酶与高血压关系的研究进展显示文摘肾素-血管紧张素系统(RAS)在血压调节中发挥了关键作用,RAS活性异常显著影响高血压疾病的发生、发展。血管紧张素转换酶(ACE)和血管紧张素转换酶2(ACE2)是RAS中的重要组成部分,这两种酶在血压调节中发挥相反作用。ACE通过其所构成的ACE-AngⅡ-AT_1R轴升高血压,而ACE2通过其所构成的ACE2-Ang1-7-MasR轴降低血压,以及ACE和ACE2之间的表达水平高低影响高血压疾病的进展。本文对ACE和ACE2在人类和动物不同类型高血压疾病中的研究进展做综述。 | 胡莹 邱长春 李静平 | 2018 | 医学研究杂志2018，47，11： | 9 |
| 19 | CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells显示文摘In face of the everlasting battle toward COVID-19 and the rapid evolution of SARS-CoV-2,no specific and effective drugs for treating this disease have been reported until today.Angiotensin-converting enzyme 2(ACE2),a receptor of SARS-CoV-2,mediates the virus infection by binding to spike protein.Although ACE2 is expressed in the lung,kidney,and intestine,its expressing levels are rather low,especially in the lung.Considering the great infectivity of COVID-19,we speculate that SARS-CoV-2 may depend on other routes to facilitate its infection.Here,we first discover an interaction between host cell receptor CD147 and SARS-CoV-2 spike protein.The loss of CD147 or blocking CD147 in Vero E6 and BEAS-2B cell lines by anti-CD147 antibody,Meplazumab,inhibits SARSCoV-2 amplification.Expression of human CD147 allows virus entry into non-susceptible BHK-21 cells,which can be neutralized by CD147 extracellular fragment.Viral loads are detectable in the lungs of human CD147(hCD147)mice infected with SARS-CoV-2,but not in those of virus-infected wild type mice.Interestingly,virions are observed in lymphocytes of lung tissue from a COVID-19 patient.Human T cells with a property of ACE2 natural deficiency can be infected with SARS-CoV-2 pseudovirus in a dosedependent manner,which is specifically inhibited by Meplazumab.Furthermore,CD147 mediates virus entering host cells by endocytosis.Together,our study reveals a novel virus entry route,CD147-spike protein,which provides an important target for developing specific and effective drug against COVID-19. | Ke Wang Wei Chen Zheng Zhang Yongqiang Deng Jian-Qi Lian Peng Du Ding Wei Yang Zhang Xiu-Xuan Sun Li Gong Xu Yang Lei He Lei Zhang Zhiwei Yang Jie-Jie Geng Ruo Chen Hai Zhang Bin Wang Yu-Meng Zhu Gang Nan Jian-Li Jiang Ling Li Jiao Wu Peng Lin Wan Huang Liangzhi Xie Zhao-Hui Zheng Kui Zhang Jin-Lin Miao Hong-Yong Cui Min Huang Jun Zhang Ling Fu Xiang-Min Yang Zhongpeng Zhao Shihui Sun Hongjing Gu Zhe Wang Chun-Fu Wang Yacheng Lu Ying-Ying Liu Qing-Yi Wang Huijie Bian Ping Zhu Zhi-Nan Chen | 2020 | Signal Transduction and Targeted Therapy2020，5，1： | 9 |
| 20 | 糖尿病肾病患者尿血管紧张素转换酶表达及培哚普利治疗后改变显示文摘目的评估糖尿病肾病合并轻、中度肾功能损害患者应用培哚普利及氯沙坦治疗后尿血管紧张素转换酶(ACE)、ACE2的改变,并观察其与肾功能损害的关系。方法 130例2型糖尿病合并糖尿病肾病患者,根据肾小球滤过率(e GFR)分为3组,慢性肾脏病(CKD)1~2期50例,CKD 3期53例,CKD 4期27例;选择50例无糖尿病患者为对照组。检测尿ACE、ACEmRNA和蛋白含量。选取CKD1~3期糖尿病肾病患者60例,分为2组,分别给予血管紧张素转换酶抑制剂(ACEI组,培哚普利片4 mg,1次/d)和血管紧张素Ⅱ受体抑制剂(ARB组,氯沙坦50 mg,1次/d)治疗12周,复查尿ACE、ACEmRNA,评估治疗前后尿白蛋白/肌酐(UACR)改变与尿ACE、ACEmRNA的相关性。结果糖尿病肾病患者尿ACE蛋白水平高于对照组[(49.92±12.45)pg/m Lvs.(6.58±2.78)pg/m L,P=0.001)。糖尿病肾病患者分组比较显示,CKD 3期组尿ACEmRNA表达(4.92±3.44)显著高于CKD1~2期组(1.77±1.86)、CKD 4期组(0.91±0.72);CKD 1~2期组尿ACEmRNA(4.43±2.66)表达显著高于CKD 3期组(2.15±1.52)、CKD 4期组(0.96±0.79)。CKD 4期组尿ACE、ACE2、ACEmRNA、ACEmRNA均明显低于CKD1~2期组、CKD 3期组。UACR与尿ACEmRNA、ACE水平呈显著正相关(r=0.402,P=0.001;r=0.187,P=0.033)。ACEI组治疗12周尿ACEmRNA表达较治疗前下降(1.91±0.99vs.2.71±1.08,P=0.027),且UACR下降率与治疗前尿ACEmRNA表达呈正相关(r=0.435,P=0.04)。结论2型糖尿病肾病患者尿ACE、ACEmRNA表达和蛋白水平与微量白蛋白尿、肾功能受损程度相关。ACEI可能通过抑制肾脏ACE表达改善微量白蛋白尿,且改善程度与尿ACEmRNA表达相关。 | 陈琳 喻明 张翠平 汪红平 陆明 | 2016 | 实用药物与临床2016，19，6： | 8 |
您所在的机构暂未开通此部分的功能，请联系管理员